Diabetes

Featured Article

Hepatitis C Virus: An Increased Risk For Type 2 Diabetes

Hepatitis C Virus: An Increased Risk For Type 2 Diabetes

Type 2 diabetes risk appears to be increased in patients with hepatitis C virus and related disorders.

Latest

ADA: Clinical Benefit With Alirocumab in T2D Plus Statin Therapy

ADA: Clinical Benefit With Alirocumab in T2D Plus Statin Therapy

Researchers presented data from the ODYSSEY DM Insulin and Dyslipidemia trials at ADA 2017.

Semaglutide Improved Beta-Cell Function and Glycemic Control in Type 2 Diabetes

Semaglutide Improved Beta-Cell Function and Glycemic Control in Type 2 Diabetes

Semaglutide significantly increased insulin response and was well-tolerated in patients with type 2 diabetes.

Cardiometabolic Disease Staging Score Useful in Quantifying T2D Risk in Overweight, Obesity

Cardiometabolic Disease Staging Score Useful in Quantifying T2D Risk in Overweight, Obesity

Cardiometabolic Disease Staging scores can be used to quantify diabetes risk and assess efficacy of weight loss pharmacotherapy in obesity.

Blood Glucose Self-Monitoring in Type 2 Diabetes Does Not Benefit Glycemic Control

Blood Glucose Self-Monitoring in Type 2 Diabetes Does Not Benefit Glycemic Control

There were no significant differences in hemoglobin A1c across the 3 self-monitoring blood glucose groups.

Improving Glycemic Control in T2D With Text Message Intervention

Improving Glycemic Control in T2D With Text Message Intervention

Three-times daily text messages over a 6 month period were found to improve glycemic control vs usual care.

Major Cardiovascular Event Incidence in T2D: Degludec vs Glargine

Major Cardiovascular Event Incidence in T2D: Degludec vs Glargine

Degludec is noninferior to glargine in terms of incidence of major cardiovascular events in patients with type 2 diabetes at high cardiovascular risk.

Hypoglycemia Effectivey Managed With New Nasal Glucagon Device

Hypoglycemia Effectivey Managed With New Nasal Glucagon Device

Hypoglycemic episodes, moderate or severe, can effectively and efficiently be managed by nasal glucagon in adult patients with type 1 diabetes.

Pooled Analysis Demonstrates Safety, Tolerability of Empagliflozin

Pooled Analysis Demonstrates Safety, Tolerability of Empagliflozin

A pooled analysis examined the rates of amputation and fracture in patients with type 2 diabetes prescribed empagliflozin.

FDA: Application Submitted for CV Safety Data Review of Insulin Degludec

FDA: Application Submitted for CV Safety Data Review of Insulin Degludec

The FDA is poised to review data from the DEVOTE trial, examining the rates of major adverse cardiovascular events in insulin degludec vs insulin glargine.

Cruciferous Vegetables May Regulate Dysglcemia In Obesity With T2D

Cruciferous Vegetables May Regulate Dysglcemia In Obesity With T2D

Sulforaphane extract from cruciferous vegetables aids in dysglycemia regulation in patients with obesity and type 2 diabetes.

Sign Up for Free e-Newsletters